5Albanese A, Barnes MP, Bhatia KP, et al. A systematic review on the diagnosis and treatment of primary ( idiopathic ) dystonia and dystonia plus syndromes: report of an EFNS/MDS-ES Task Force. EurJ Neurol, 2006,13: 433-444.
6Klein C, Friedman J, Bressman S, et al. Genetic testing for earlyonset torsion dystonia ( DYT1 ) : introduction of a simple screening method, experiences from testing of a large patient cohort, and ethical aspects. Genet Test, 1999, 3:323-328 .
7Bressman SB, Sabatti C, Raymond D, et al. The DYT1 phenotype and guidelines for diagnostic testing. Neurology, 2000, 54: 1746- 1752.
8Robinson R, McCarthy GT, Bandmann O, et al. GTP cyclohydrolase deficiency; intrafamilial variation in clinical phenotype, including levodopa responsiveness. J Neurol Neurosurg Psychiatry, 1999, 66 : 86-89.
9Valente EM, Edwards MJ, Mir P, et al. The epsilon-sarcoglycan gene in myoclonic syndromes. Neurology, 2005, 64: 737-739.
10Meunier S, Lehericy S, Gamero L, et al. Dystonia: lessons from brain mapping . Neuroscientist, 2003, 9: 76-81.
3Goodchild R,Grundmann K,Pisani A.New genetic insights high-light ' old ' ideas on motor dysfunction in dystonia[J].Trends in Neurosciences,2013,36(12):717-725.
4Ozelius IJ,Lubarr N,Bressman SB.Milestones in dystonia[J].Movement Disorders,2011,26:1104-1026.
5Petrucci S,Valente EM.Genetic issues in the diagnosis of dysto-nias[J],Fronter in Neurology,2013,4:34.
6Albanese A,Lalli S.Update on dystonia[J].Curr Opin Neurol,2012,25:483-490.
7Kenney C,Jankovic J. Botulinum toxin in the treat-ment of blepharospasm and hemifacial spasm[J]. J Neural Transm, 2008,115 (4) : 585-591.
8Silveira-Moriyama L, Gonsalves LR, Chien I-IF, et al.Bo- tulinum toxin A in the treatment of blepharospasm, 10- year experience[J]. Arq Neuropsiquiatr, 2005,63 (2A) : 221- 224.
9Bentivoglio AR, Fasano A,Ialongo T, et al. Fifteen-year experience in treating blepharospasm with Botox or Dys- port : Same toxin, two drugs[J]. Neurotox Res, 2009,15 (3) : 224-231.
10Albanese A,Barnes MP, Bhatia KP, et al. A systematic re- view on the diagnosis and treatment of primary (idiopath- ic) dystonia and dystonia plus syndromes. Report by an EFNS/MDS-ES task force[J]. Eur J Neurol, 2006, 13 (5) : 433-444.
